DOXORUBICINOL, THE METABOLITE OF DOXORUBUCIN, IS MORE CARDIOTOXIC THAN DOXORUBICIN

被引：13
作者：
BOUCEK, RJ
KUNKEL, EM
GRAHAM, TP
BRENNER, D
OLSON, RD
机构：
[1] VANDERBILT UNIV,MED CTR,SCH MED,DEPT PEDIAT,NASHVILLE,TN 37232
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
[3] VET ADM MED CTR,BOISE,ID
来源：
PEDIATRIC RESEARCH | 1987年 / 21卷 / 04期
关键词：
D O I：
10.1203/00006450-198704010-00127
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：A187 / A187
页数：1
相关论文
共 50 条
  • [21] β-hydroxybutyrate: Much more than a metabolite
    Newman, John C.
    Verdin, Eric
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 (02) : 173 - 181
  • [22] EFFECT OF PHENYTOIN ON THE PHARMACOKINETICS OF DOXORUBICIN AND DOXORUBICINOL IN THE RABBIT
    CUSACK, BJ
    TESNOHLIDEK, DA
    LOSEKE, VL
    VESTAL, RE
    BRENNER, DE
    OLSON, RD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (04) : 294 - 298
  • [23] ALCOHOL PLUS COCAINE IS MORE CARDIOTOXIC THAN ALCOHOL OR COCAINE ALONE
    HENNING, RJ
    WILSON, LD
    GLAUSER, JM
    SUTHEIMER, CA
    LAVINS, E
    CLINICAL RESEARCH, 1993, 41 (02): : A384 - A384
  • [24] Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin
    Harahap, Yahdiana
    Ardiningsih, Puspitasari
    Winarti, Agatha Corintias
    Purwanto, Denni Joko
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 3469 - 3475
  • [25] COCAINE PLUS ETHANOL IS MORE CARDIOTOXIC THAN COCAINE OR ETHANOL ALONE
    HENNING, RJ
    WILSON, LD
    GLAUSER, JM
    CRITICAL CARE MEDICINE, 1994, 22 (12) : 1896 - 1906
  • [26] DOXORUBICIN AND DOXORUBICINOL - INTRAINDIVIDUAL AND INTERINDIVIDUAL VARIATIONS OF PHARMACOKINETIC PARAMETERS
    JACQUET, JM
    BRESSOLLE, F
    GALTIER, M
    BOURRIER, M
    DONADIO, D
    JOURDAN, J
    ROSSI, JF
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 27 (03) : 219 - 225
  • [27] COMPARATIVE ACTIVITY OF DOXORUBICIN AND ITS MAJOR METABOLITE, DOXORUBICINOL, ON V79/AP4 FIBROBLASTS - A MORPHOFUNCTIONAL STUDY
    BERNARDINI, N
    GIANNESSI, F
    BIANCHI, F
    DOLFI, A
    LUPETTI, M
    ZACCARO, L
    MALVALDI, G
    DELTACCA, M
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1991, 55 (03) : 238 - 250
  • [28] CELLULAR PHARMACOLOGY OF DOXORUBICIN OR ITS METABOLITE DOXORUBICINOL COMBINED WITH VERAPAMIL IN SENSITIVE AND RESISTANT PANCREATIC-CANCER CELL-LINES
    CHANG, BK
    BRENNER, DE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 394 - 394
  • [29] Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC-MS/MS in human plasma of HCC patients treated with TACE
    Sottani, Cristina
    Poggi, Guido
    Melchiorre, Fabio
    Montagna, Benedetta
    Minoia, Claudio
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2013, 915 : 71 - 78
  • [30] FLUOROURACIL AND DOXORUBICIN - CARDIOTOXIC CYTOSTATICS IN THE WORKPLACE
    Kupczewska-Dobecka, Malgorzata
    Czerczak, Slawomir
    MEDYCYNA PRACY, 2020, 71 (03) : 363 - 373
12345